Seres Therapeutics MCRB
NASDAQ MCRB
$2.30 -0.01 (-0.43%)
At close: Oct 21, 2026 · 4:00 PM EDT

Seres Therapeutics (MCRB) Total Non-Current Liabilities (2014 - 2026)

Updated

Seres Therapeutics (MCRB) posted Total Non-Current Liabilities of $64.85 million for Q2 2026, down 40.5% from $108.9 million a year earlier and down 27.1% from the prior quarter.

Analysis

Seres Therapeutics (MCRB) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, Seres Therapeutics' Total Non-Current Liabilities came in at $91.9 million, down 26.0% from FY2024.

  • Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of -11.3% (FY2020 to FY2025).
  • In prior years, Seres Therapeutics' Total Non-Current Liabilities was $124.19 million in FY2024 (-69.1%), $401.83 million in FY2023 (+19.4%), $336.56 million in FY2022 (+58.9%) and $211.86 million in FY2021 (+26.7%).
  • The Q2 2026 figure stands as the lowest quarterly Total Non-Current Liabilities since Q4 2015.
  • On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last eight quarters, with an average decline of 49.6% over the last eight quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q4 2022, with growth of 58.9%; the weakest was Q2 2025, with a decline of 73.2%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $88.98 million (Q1 2026), $91.9 million (Q4 2025) and $97.76 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 106.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.10 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 97.04 Bn
10 Seres Therapeutics 22.42 Mn -116.41 Mn - 64.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 64.85 Mn
Mar 31, 2026 88.98 Mn
Dec 31, 2025 91.90 Mn
Sep 30, 2025 97.76 Mn
Jun 30, 2025 108.90 Mn
Mar 31, 2025 111.82 Mn
Dec 31, 2024 124.19 Mn
Sep 30, 2024 153.04 Mn
Jun 30, 2024 407.08 Mn
Mar 31, 2024 399.19 Mn
Dec 31, 2023 401.28 Mn
Sep 30, 2023 380.29 Mn
Jun 30, 2023 380.27 Mn
Mar 31, 2023 316.58 Mn
Dec 31, 2022 336.56 Mn
Sep 30, 2022 243.32 Mn
Jun 30, 2022 249.20 Mn
Mar 31, 2022 235.03 Mn
Dec 31, 2021 211.86 Mn
Sep 30, 2021 212.35 Mn
API Access

Seres Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MCRB&period=max&api_key=YOUR_API_KEY